You are here

Testing and counselling

European Prevention Curriculum 2019 EMCDDA

European Prevention Curriculum

by
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

A handbook for decision-makers, opinion-makers and policy-makers in science-based prevention of substance use

This handbook has been developed with the primary purpose of providing specific reference material for the European Prevention Curriculum (EUPC) training courses. It also serves...

Tags: Health care professionals, NGOs, Policy makers, Global, Advocacy, Care and support, Harm reduction, Testing and counselling, Treatment
Read more
HA-REACT 3rd Laymans Report 2019

Summary of the Activities and Results of the Joint Action on HIV and Co-Infection Prevention and Harm Reduction (HA-REACT)

by
HA-REACT - Joint Action on HIV and Co-infection Prevention and Harm Reduction

Reporting Period: October 2015 – January 2019

The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis and viral hepatitis, among people who inject drugs.

The ...

Tags: Health care professionals, NGOs, Policy makers, WHO European region, Advocacy, Capacity building, Harm reduction, Prevention, Quality development and assurance, Resource mobilisation, STI's, Testing and counselling, Treatment, Tubercolosis, Viral hepatitis
Read more
Public health guidance on active case finding of communicable diseases in prison settings 2018

Public health guidance on active case finding of communicable diseases in prison settings

by
European Centre for Disease Prevention and Control (ECDC), European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

This document provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.

Tags: General public, Health care professionals, People living with HIV (PLHIV), People who are/were in prisons, Policy makers, WHO European region, Advocacy, Care and support, Harm reduction, Inequalities in health, Monitoring and Evaluation, Prevention, Testing and counselling, Tubercolosis, Viral hepatitis
Read more

CBVCT Services - Current obstacles and opportunities

by
Fondazione LILA Milano ONLUS

This Advocacy Tool addresses gaps and challenges for the cross-sectoral cooperation in the field of CBVCT in Europe. This study assembles the opinions and ideas of different stakeholders who provided very diverse points of view on the subject, because as they play different roles at the national...

Tags: Health care professionals, NGOs, Policy makers, WHO European region, Advocacy, Harm reduction, Laws and regulations, Research, Testing and counselling
Read more
Poster: Contest to illustrate the documents on OST in prisons in Poland

Poster: Contest to illustrate the documents on OST in prisons in Poland

by
Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT)

"Konkurs na ilustrację do materiałów szkoleniowych na temat: Leczenie substytucyjne" - This  poster and leaflet for the inmates of a penitentiary center Sluzew (Warsaw) is prepared by the National AIDS Centre in Poland. The inmates will be asked to illustrate the documents on OST in prisons (...

Tags: Injecting drug users (IDUs), People who are/were in prisons, People who use drugs (PUD), Prisoners (ex-), Central Europe, Harm reduction, Testing and counselling
Read more

SUMMARY OF THE PERIODIC TECHNICAL REPORT JOINT ACTION ON HIV AND CO-INFECTION PREVENTION AND HARM REDUCTION

by
HA-REACT

The Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT) addresses existing gaps in the prevention of HIV and other co-infections, especially tuberculosis (TB) and viral hepatitis. Here you can find a summary of the periodic technical report of HA-REACT.

Tags: Health care professionals, Injecting drug users (IDUs), Policy makers, Prisoners (ex-), Sex workers, WHO European region, Advocacy, HIV and labor, Human rights, Laws and regulations, Testing and counselling, Treatment, Treatment as prevention (TasP), Tubercolosis, Viral hepatitis
Read more
AIDS Action Europe Strategic Framework 2015-2017

AAE Strategic Framework 2015-2017: Continuity and Innovation - Towards a more effective Response to HIV

by
© AIDS Action Europe c/o Deutsche AIDS-Hilfe e.V.

The AAE Steering Committee has defined an overall strategy and clear agenda spanning 2015–2017 that align AAE’s work with growing concerns. Through this, we will strengthen our response to the epidemic, maintain our commitments and provide a framework in which we can prioritise our actions....

Tags: General public, Health care professionals, WHO European region, Advocacy, Affordability, Capacity building, Care and support, Human rights, Laws and regulations, Migration, Prevention, Resource mobilisation, Stigma and discrimination, Testing and counselling, Treatment
Read more
Integrate and Partner Notification 2019

Integrate and Partner Notification

by
Lella Cosmaro, Fondazione LILA Milano ONLUS, Italy

Lella Cosmaro, working at Fondazione LILA Milano ONLUS, Italy, former AIDS Action Europe (AAE) Steering Committee Member, introduced during AAE's Member and Partner Meeting 2019 the Joint Action on integrating prevention, testing and linkage to care strategies across HIV, viral hepatitis, TB and...

Tags: Health care professionals, NGOs, Policy makers, WHO European region, Affordability, Care and support, Co-infections, Epidemiology, Harm reduction, Human rights, Laws and regulations, Monitoring and Evaluation, Policy, Positive prevention, Post-exposure prophylaxis (PeP), Pre-exposure prophylaxis (PrEP), Prevention, STI's, Stigma and discrimination, Testing and counselling, Treatment as prevention (TasP), Tubercolosis, Viral hepatitis
Read more
An assessment of barriers to access to HIV and HCV services for people who inject drugs in Europe

Report on PWID barriers to accessing HIV, HCV and TB services and on strategies for overcoming these barriers

by
Joint Action on HIV and Co-infection Prevention and Harm Reduction (HA-REACT)

People who inject drugs (PWID) have become one of the most vulnerable populations in Europe to not only get infected by HIV and/or hepatitis C (HCV) but also to not be able to access testing, care and treatment services. In order to reach UNAIDS goals to end HIV and WHO goals to eliminate HCV in...

Tags: Health care professionals, WHO European region, Affordability, Care and support, Harm reduction, Monitoring and Evaluation, Testing and counselling
Read more

Twitter News